The same group confirmed the decrease of CD4+CD25highCD127− Treg cell counts was associated with an increased risk to develop CLAD, irrespective of the RAS or BOS diagnostic, in a retrospective longitudinal analysis of 137 patients. This evidence concerns the gene CD4 and Buschke-Ollendorff syndrome.